Lombard Odier Asset Management (USA)’s Medifast MED Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,448	Closed	-$554K	–	348
2024 Q1	$554K	Buy	+14,448	New	+$700K	0.01%	236
2023 Q4	–	Sell	-8,504	Closed	-$637K	–	399
2023 Q3	$637K	Buy	8,504 +949	+13%	+$84.2K	0.01%	232
2023 Q2	$696K	Buy	7,555 +3,772	+100%	+$336K	0.01%	236
2023 Q1	$392K	Buy	+3,783	New	+$419K	0.01%	227
2022 Q4	–	Sell	-3,678	Closed	-$399K	–	370
2022 Q3	$399K	Buy	+3,678	New	+$527K	0.01%	268
2021 Q2	–	Sell	-22,650	Closed	-$4.8M	–	341
2021 Q1	$4.8M	Buy	+22,650	New	+$5.42M	0.18%	76
2020 Q4	–	Sell	-40,000	Closed	-$6.58M	–	299
2020 Q3	$6.58M	Sell	40,000 -53,705	-57%	-$8.84M	0.43%	57
2020 Q2	$13M	Buy	93,705 +78,470	+515%	+$7.2M	0.91%	22
2020 Q1	$952K	Sell	15,235 -161,402	-91%	-$14.7M	0.1%	144
2019 Q4	$19.4M	Buy	+176,637	New	+$17.1M	1.73%	11
2019 Q3	–	Sell	-87,266	Closed	-$11.2M	–	279
2019 Q2	$11.2M	Buy	87,266 +15,798	+22%	+$2.19M	0.9%	37
2019 Q1	$9.12M	Buy	+71,468	New	+$9.06M	0.75%	43
2018 Q4	–	Sell	-12,000	Closed	-$2.66M	–	251
2018 Q3	$2.66M	Buy	+12,000	New	+$2.43M	0.2%	141

Other funds holding MED

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s MED Position: Q2 2024 in Review

Lombard Odier Asset Management (USA) sold out of Medifast (MED) in Q2 2024, closing a stake of 14,448 shares — an estimated $554K sold.

Lombard Odier Asset Management (USA) first reported a position in MED in Q3 2018 and held it in 13 quarters. The position peaked at $19.4M in Q4 2019. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

Lombard Odier Asset Management (USA) reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 14,448 Medifast shares in Q2 2024, an estimated $554K.
Lombard Odier Asset Management (USA) first reported a position in Medifast in Q3 2018 and held it in 13 quarters.
Lombard Odier Asset Management (USA)'s Medifast position peaked at $19.4M in Q4 2019.
158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2024, filed 14 Aug 2024.